Pillyze develops a nutrition analysis platform intended to manage healthy functional food and pharmaceutical intake.
Pillyze has raised $9.0M in total funding. The most recent round was Series A. The last funding was announced in August 2023.
Pillyze's investors include Samsung NEXT, Strong Ventures, Capstone Partners, Nextrans, Korea Development Bank.
Pillyze is headquartered in Seoul, South Korea.
Pillyze develops a nutrition analysis platform intended to manage healthy functional food and pharmaceutical intake.
Pillyze is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pillyze — Funding & Investors." VCBacked, August 22, 2023, https://www.vcbacked.co/company/pillyze. Accessed July 20, 2026.
VCBacked. (2023). Pillyze — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/pillyze
{{cite web |title=Pillyze — Funding & Investors |url=https://www.vcbacked.co/company/pillyze |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated